Eli Lilly and Gate Bioscience have expanded their collaboration to discover, develop, and commercialise molecular gate therapeutics.   The expanded collaboration adds one target, with the opportunity to add a second target, to the companies’ existing work.   The programmes leverage Gate’s Molecular Gate drug discovery engine to identify medicines capable of eliminating specific difficult-to-drug proteins in […]